While the focus of the present research was on the role of FOXA1 in BLCa cells, tissue recombination xenografting enables the incorporation of bladder mesenchyme associated determinants of disease in future studies [62], [63], [64]. This evidence concerns the gene FOXA1 and bladder transitional cell carcinoma.